CoagulationDisorders near Bronx, NY

Biography: Maria Garzon, M.D. is Professor of Dermatology and Pediatrics at Columbia University Vagelos College of Physicians and Surgeons (VP&S) and the Director of the Division of Pediatric Dermatology at NYP Morgan Stanley Children's Hospital. With a significant body of published research, leadership and teaching experience, Dr. Garzon is an internationally recognized leader in pediatric dermatology. She is a leading expert on the care of children and adolescents with vascular anomalies, particularly hemangiomas and vascular malformations. Dr. Garzon is the Founder and Co-Director of the NYP/Columbia University Irving Medical Center (NYP/CUIMC) Interdisciplinary Vascular Anomalies Group, a founding member and past President of the Hemangioma Investigator Group (HIG) and a founding member of the Pediatric Dermatology Research Alliance (PeDRA). She is a past President of both the Society for Pediatric Dermatology and the New York Dermatological Society. She was elected to the Academy of Clinical Excellence (ACE) at VP&S and named a Samberg Scholar at NYP Morgan Stanley Children's Hospital. Dr. Garzon has authored numerous articles and book chapters and has lectured at many national and international meetings including the American Academy of Dermatology, American Academy of Pediatrics, Pediatric Academic Societies, World Congress of Pediatric Dermatology, National Institute of Health and International Society for the Study of Vascular Anomalies. Dr. Garzon has been named a top doctor by Castle Connolly, Best Doctors and New York Magazine.Dr. Garzon received her undergraduate degree from Harvard University and her medical degree from Columbia University College of Physicians and Surgeons where she was elected to Alpha Omega Alpha Honor Society. She completed her Pediatric residency at the former Babies Hospital, Columbia Presbyterian Medical Center (now New York-Presbyterian Morgan Stanley Children's Hospital) and dermatology residency at NYP Columbia University Medical Center. She was a fellow in pediatric dermatology at Children's Memorial Hospital, Northwestern University in Chicago, IL. She is a fellow of the American Academy of Dermatology and American Academy of Pediatrics and a member of the Society for Pediatric Dermatology, American Dermatologic Association, Hemangioma Investigator Group, International Society for the Study of Vascular Anomalies, Pediatric Dermatology Research Alliance, Society for Investigative Dermatology, and Women's Dermatologic Society.

Care Philosophy: We are committed to delivering the best care and an exceptional patient experience. We are devoted to providing services that are patient-centered and compassionate, and care for you as a person.

Biography: Paul Chapman, MD is currently the Chief Medical Research Officer for the Meyer Cancer Center at Weill Cornell Medicine and NewYork-Presbyterian Hospital. Dr. Chapman received his M.D. degree from Weill Cornell Medical College in 1981 and trained in internal medicine as an intern and resident at the University of Chicago Hospitals and Clinics from 1981-1984. After that, he returned to New York as a medical oncology Fellow at Memorial Sloan Kettering Cancer where he focused on immunotherapy of melanoma in the laboratory of Dr. Alan Houghton. He joined the faculty of Memorial Sloan Kettering Cancer Center (MSKCC) in 1988 and worked there through 2023 as a tenured Attending Physician. During this time at MSKCC, Dr. Chapman led many clinical and laboratory studies designed to develop new and improved treatments for melanoma. This included the first BRAF targeted therapy trial and several immunotherapy trials. His research continues to focus on developing new treatments for melanoma.

Biography: Daniel Choi, MD, is an Instructor in Medicine at Weill Cornell Medical College and an Assistant Attending Physician at the New York-Presbyterian Hospital. Dr. Choi earned his medical degree from the Icahn School of Medicine at Mount Sinai in New York in 2016. He completed his residency training in Internal Medicine at Montefiore Medical Center in the Bronx in 2019 and his fellowship training in Hematology and Medical Oncology at NewYork-Presbyterian Hospital/Weill Cornell Medicine in 2022.Dr. Choi is a physician-scientist conducting laboratory research focused on the stem cell biology of myeloproliferative neoplasms (MPNs). In addition to his laboratory research, he specializes in the clinical care of patients with myeloid malignancies including MPNs and leukemias at Weill Cornell Medicine.

Care Philosophy: My clinical interests include working with children with various blood disorders, such as sickle cell anemia, blood clotting disorders, and rare disorders called Myeloproliferative Neoplasms. I find it a privilege to be able to help families deal with their children's complex medical issues. By combining excellent, compassionate medical care with research aimed at improving outcomes and preventing disease-associated complications, I believe that we can make a difference for children with cancer and blood disorders.

Care Philosophy: My philosophy is simple: the patient comes first. As part of the Genitourinary Oncology Program at Weill Cornell Medicine, I am committed to delivering the best care to my patients. Our world-class multidisciplinary team ensures that we treat the patient as a whole, not just the cancer. I am driven by the desire to improve therapy of urological malignancies by identifying the genetic "Achilles heel" of each patient's cancer. Through my research, I am committed to developing "precision medicine" approaches and conducting clinical trials for treatment of bladder cancer and other genitourinary malignancies.

Biography: Nora Chokr, M.D., is an Assistant Professor of Medicine in the Division of Hematology and Medical Oncology at Weill Cornell Medicine/ NewYork-Presbyterian Hospital. She specializes in the care of patients with blood disorders who are in need of bone marrow or stem cell transplantation or cellular-based therapies, like chimeric antigen receptor (CAR) T-cell therapy. Dr. Chokr received her medical degree from the American University of Beirut Medical Center in Lebanon in 2015. She completed her Internal Medicine residency at Yale New Haven Hospital and her Hematology/Oncology fellowship at SUNY Downstate Medical Center, where she served as a Chief Fellow. Subsequently, she completed an advanced fellowship in Bone Marrow Transplantation and Immune Effector Cell Therapy at Weill Cornell Medicine (WCM)/NewYork-Presbyterian (NYP) Hospital. Upon completion of this advanced fellowship training, Dr. Chokr was recruited to join the faculty of the WCM/NYP Bone Marrow Transplantation Program. Dr. Chokr's main research interests focus on increasing transplant access and optimizing outcomes in older patients. Her interests also include the prevention of disease relapse and graft vs host disease after transplant. Dr. Chokr is an investigator for several clinical trials that aim to advance the field. She has publications in leading international peer-reviewed journals, and is a member of the American Society of Hematology (ASH), American Society for Transplantation and Cellular Therapy (ASTCT), ASTCT Aging Special Interest Group, Cancer and Aging Research Group (CARG). Dr. Chokr is also involved in teaching medical students, residents and fellows.

Biography: Alana Nguyen, MD PhD, is an Assistant Professor in the Division of Hematology and Oncology at Weill Cornell Medicine/NewYork-Presbyterian Hospital.Dr. Nguyen received her MD from Boston University in Boston, Massachusetts and herPhD from McGill University in Montreal, Canada. She went on to complete her postgraduate medical training in Internal Medicine at the Mount Sinai Hospital in New York City. After her residency, she entered fellowship training in Medical Oncology at Columbia University/New York-Presbyterian Hospital in the Physician-Scientist Pathway.Dr. Nguyen sees patients with malignancies of the digestive tract in her clinical practice.In addition, her research focuses on drug development based on biological understanding of therapy resistance. She received a Women Who Conquer Cancer Award from the American Society for Clinical Oncology and its Conquer Cancer Foundation for her work on a 3-dimensional culture model of patient tumors to predict for patients' response to chemotherapy and immunotherapy. Using this innovative model, her current research will focus on understanding the tumor microenvironment of pancreatic cancer, and how this tumor microenvironment participates in drug evasion.